Identification of MEFV-independent modifying genetic factors for familial Mediterranean fever.

[1]  R. Kisilevsky.  Amyloids: Tombstones or triggers? , 2000, Nature Medicine.

[2]  E R McCabe,et al.  Phenotypes of patients with "simple" Mendelian disorders are complex traits: thresholds, modifiers, and systems dynamics. , 2000, American journal of human genetics.

[3]  C. Soto,et al.  Receptor-dependent cell stress and amyloid accumulation in systemic amyloidosis , 2000, Nature Network Boston.

[4]  N. Kamatani,et al.  Influence of genotypes at SAA1 and SAA2 loci on the development and the length of latent period of secondary AA-amyloidosis in patients with rheumatoid arthritis , 1999, Human Genetics.

[5]  J. Kouyoumdjian,et al.  MEFV-Gene analysis in armenian patients with Familial Mediterranean fever: diagnostic value and unfavorable renal prognosis of the M694V homozygous genotype-genetic and therapeutic implications. , 1999, American journal of human genetics.

[6]  J. Liepnieks,et al.  A cell culture system for the study of amyloid pathogenesis. Amyloid formation by peritoneal macrophages cultured with recombinant serum amyloid A. , 1999, The American journal of pathology.

[7]  T. Shohat,et al.  Phenotype–genotype correlation in familial Mediterranean fever: evidence for an association between Met694Val and amyloidosis , 1999, European Journal of Human Genetics.

[8]  D. Booth,et al.  SAA1 alleles as risk factors in reactive systemic AA amyloidosis. , 1998, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

[9]  Klaus Zerres,et al.  Identification of a candidate modifying gene for spinal muscular atrophy by comparative genomics , 1998, Nature Genetics.

[10]  D. Booth,et al.  Pyrin/marenostrin mutations in familial Mediterranean fever. , 1998, QJM : monthly journal of the Association of Physicians.

[11]  J. Weissenbach,et al.  Non-founder mutations in the MEFV gene establish this gene as the cause of familial Mediterranean fever (FMF). , 1998, Human molecular genetics.

[12]  N. Akar,et al.  Familial Mediterranean fever--amyloidosis and the Val726Ala mutation. , 1998, The New England journal of medicine.

[13]  D. Zemer,et al.  Criteria for the diagnosis of familial Mediterranean fever. , 1997, Arthritis and rheumatism.

[14]  Jacques Demaille,et al.  A candidate gene for familial Mediterranean fever , 1997, Nature Genetics.

[15]  F. Collins,et al.  Ancient Missense Mutations in a New Member of the RoRet Gene Family Are Likely to Cause Familial Mediterranean Fever , 1997, Cell.

[16]  J. Liepnieks,et al.  Differential plasma clearance of murine acute-phase serum amyloid A proteins SAA1 and SAA2. , 1997, The Biochemical journal.

[17]  M. Komajda,et al.  The influence of the angiotensin I converting enzyme genotype in familial hypertrophic cardiomyopathy varies with the disease gene mutation. , 1997, Journal of molecular and cellular cardiology.

[18]  M. Pras,et al.  Apolipoprotein E Carboxyl-terminal Fragments Are Complexed to Amyloids A and L , 1995, The Journal of Biological Chemistry.

[19]  S. Tsugane,et al.  A novel allelic variant of serum amyloid A, SAA1 gamma: genomic evidence, evolution, frequency, and implication as a risk factor for reactive systemic AA-amyloidosis. , 1995, Human molecular genetics.

[20]  J. Liepnieks,et al.  Characterization of amyloid A protein in human secondary amyloidosis: the predominant deposition of serum amyloid A1. , 1995, Biochimica et biophysica acta.

[21]  T Vogel,et al.  Acceleration of Alzheimer's fibril formation by apolipoprotein E in vitro. , 1994, The American journal of pathology.

[22]  Giovanni Romeo,et al.  Phenotypic diversity, allelic series and modifier genes , 1994, Nature Genetics.

[23]  P Brown,et al.  Fatal familial insomnia and familial Creutzfeldt-Jakob disease: disease phenotype determined by a DNA polymorphism. , 1992, Science.

[24]  Thomas Wisniewski,et al.  Apolipoprotein E: A pathological chaperone protein in patients with cerebral and systemic amyloid , 1992, Neuroscience Letters.

[25]  D. Zemer,et al.  Colchicine in the prevention and treatment of the amyloidosis of familial Mediterranean fever. , 1986, The New England journal of medicine.

[26]  R. Meek,et al.  Amyloidogenesis. One serum amyloid A isotype is selectively removed from the circulation , 1986, The Journal of experimental medicine.

[27]  V. Marks,et al.  Biochemistry in Clinical Practice , 1985 .

[28]  E. Sohar,et al.  FAMILIAL MEDITERRANEAN FEVER , 1959, Definitions.

[29]  J. Feingold.  Les gènes modificateurs dans les maladies héréditaires. , 2000 .

[30]  Jean Génermont,et al.  Les gènes modificateurs dans les maladies héréditaires , 2000 .

[31]  T. Yamada,et al.  Serum amyloid A1 alleles and plasma concentrations of serum amyloid A. , 1999, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

[32]  E. Uro-Coste,et al.  [Fatal familial insomnia]. , 1999, Clinical and experimental pathology.

[33]  A. Bernot,et al.  Phenotype-genotype correlation in Jewish patients suffering from familial Mediterranean fever (FMF) , 1998, European Journal of Human Genetics.

[34]  J. Whicher.  Abnormalities of Plasma Proteins , 1994 .

[35]  M A Pericak-Vance,et al.  Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. , 1993, Neurology.

[36]  J. Meyerhoff.  Familial Mediterranean fever: report of a large family, review of the literature, and discussion of the frequency of amyloidosis. , 1980, Medicine.